FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108673054> ?p ?o ?g. }

• W2108673054 endingPage "190" @default.
• W2108673054 startingPage "182" @default.
• W2108673054 abstract "To determine the clinical outcome, prognostic factors, and effect of adding combination chemotherapy to radiation therapy on disease control and survival in early stage nasal natural killer (NK)/T-cell lymphoma.A retrospective intent to treat analysis was carried out on 79 patients treated consecutively with curative intent between 1977 and June 2001. They all had early stage (Ann Arbor Stage I(E): 63, II(E):16) nasal NK/T-cell lymphoma. Sixty-one were planned for combined modality treatment (CMT); radiotherapy alone (RT) was intended for 18. Three to 6 cycles of anthracycline-containing regimens were aimed at for patients intended for CMT. Patients selected for RT were generally older or treated during the earlier part of the study period.The overall complete response (CR) rate was 68.4% (54/79), of whom 44.4% (24/54) relapsed after 54.9 months median follow-up of the survivors. The 5-year disease-free survival (DFS) and overall survival (OS) rates were 35.5% and 37.9%, respectively. On multivariate analysis, good performance status (Eastern Cooperative Oncology Group [ECOG] <2) was shown to be a significant favorable factor for DFS (p = 0.011), whereas good performance status (ECOG <2) and Ann Arbor Stage I(E) disease were shown to be significant favorable factors for OS (p = 0.001 and p = 0.013, respectively). The type of intended treatment was not a significant factor for DFS (5-year DFS CMT vs. RT = 35.8% vs. 30.5%, p = 0.795) or OS (5-year OS CMT vs. RT = 40.3% vs. 29.8%, p = 0.693) though only 2 of the 16 Stage II(E) patients were intended for RT alone. Resistance to treatment, especially to chemotherapy, was common. Of 61 patients intended to be given CMT, 31 showed disease progression while receiving chemotherapy, of whom 17 progressed locoregionally. Nine of the latter group were rendered CR by salvage radiotherapy.The overall outcome in early stage nasal NK/T-cell lymphoma is poor. Performance status and Ann Arbor stage are significant factors influencing DFS and OS. The addition of anthracycline-containing chemotherapy to radiotherapy does not appear to confer any survival benefit in Stage I(E) patients. Therefore, radiation therapy remains the mainstay of treatment for this lymphoma type." @default.
• W2108673054 created "2016-06-24" @default.
• W2108673054 creator A5007167749 @default.
• W2108673054 creator A5007685527 @default.
• W2108673054 creator A5013727777 @default.
• W2108673054 creator A5043688168 @default.
• W2108673054 creator A5066486602 @default.
• W2108673054 date "2002-09-01" @default.
• W2108673054 modified "2023-10-16" @default.
• W2108673054 title "Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality" @default.
• W2108673054 cites W1599858297 @default.
• W2108673054 cites W1819949687 @default.
• W2108673054 cites W1834678085 @default.
• W2108673054 cites W1843358390 @default.
• W2108673054 cites W1892168086 @default.
• W2108673054 cites W1974720011 @default.
• W2108673054 cites W1979234199 @default.
• W2108673054 cites W1980634883 @default.
• W2108673054 cites W1985239180 @default.
• W2108673054 cites W1986884101 @default.
• W2108673054 cites W1988252772 @default.
• W2108673054 cites W1993124969 @default.
• W2108673054 cites W1997353354 @default.
• W2108673054 cites W1999640894 @default.
• W2108673054 cites W1999663037 @default.
• W2108673054 cites W2012759826 @default.
• W2108673054 cites W2015638173 @default.
• W2108673054 cites W2022388117 @default.
• W2108673054 cites W2026540048 @default.
• W2108673054 cites W2051663152 @default.
• W2108673054 cites W2060596579 @default.
• W2108673054 cites W2064347805 @default.
• W2108673054 cites W2071211798 @default.
• W2108673054 cites W2074287871 @default.
• W2108673054 cites W2090821308 @default.
• W2108673054 cites W2104226988 @default.
• W2108673054 cites W2107202569 @default.
• W2108673054 cites W2111849687 @default.
• W2108673054 cites W2117291755 @default.
• W2108673054 cites W2131153411 @default.
• W2108673054 cites W2140998439 @default.
• W2108673054 cites W2274420705 @default.
• W2108673054 cites W2339293928 @default.
• W2108673054 cites W4205736005 @default.
• W2108673054 cites W4293241248 @default.
• W2108673054 doi "https://doi.org/10.1016/s0360-3016(02)02916-4" @default.
• W2108673054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12182990" @default.
• W2108673054 hasPublicationYear "2002" @default.
• W2108673054 type Work @default.
• W2108673054 sameAs 2108673054 @default.
• W2108673054 citedByCount "258" @default.
• W2108673054 countsByYear W21086730542012 @default.
• W2108673054 countsByYear W21086730542013 @default.
• W2108673054 countsByYear W21086730542014 @default.
• W2108673054 countsByYear W21086730542015 @default.
• W2108673054 countsByYear W21086730542016 @default.
• W2108673054 countsByYear W21086730542017 @default.
• W2108673054 countsByYear W21086730542018 @default.
• W2108673054 countsByYear W21086730542019 @default.
• W2108673054 countsByYear W21086730542020 @default.
• W2108673054 countsByYear W21086730542021 @default.
• W2108673054 countsByYear W21086730542022 @default.
• W2108673054 countsByYear W21086730542023 @default.
• W2108673054 crossrefType "journal-article" @default.
• W2108673054 hasAuthorship W2108673054A5007167749 @default.
• W2108673054 hasAuthorship W2108673054A5007685527 @default.
• W2108673054 hasAuthorship W2108673054A5013727777 @default.
• W2108673054 hasAuthorship W2108673054A5043688168 @default.
• W2108673054 hasAuthorship W2108673054A5066486602 @default.
• W2108673054 hasConcept C126322002 @default.
• W2108673054 hasConcept C141071460 @default.
• W2108673054 hasConcept C143998085 @default.
• W2108673054 hasConcept C146357865 @default.
• W2108673054 hasConcept C151730666 @default.
• W2108673054 hasConcept C167135981 @default.
• W2108673054 hasConcept C2776694085 @default.
• W2108673054 hasConcept C2777589544 @default.
• W2108673054 hasConcept C2779338263 @default.
• W2108673054 hasConcept C2779714933 @default.
• W2108673054 hasConcept C38180746 @default.
• W2108673054 hasConcept C509974204 @default.
• W2108673054 hasConcept C71924100 @default.
• W2108673054 hasConcept C86803240 @default.
• W2108673054 hasConcept C90924648 @default.
• W2108673054 hasConceptScore W2108673054C126322002 @default.
• W2108673054 hasConceptScore W2108673054C141071460 @default.
• W2108673054 hasConceptScore W2108673054C143998085 @default.
• W2108673054 hasConceptScore W2108673054C146357865 @default.
• W2108673054 hasConceptScore W2108673054C151730666 @default.
• W2108673054 hasConceptScore W2108673054C167135981 @default.
• W2108673054 hasConceptScore W2108673054C2776694085 @default.
• W2108673054 hasConceptScore W2108673054C2777589544 @default.
• W2108673054 hasConceptScore W2108673054C2779338263 @default.
• W2108673054 hasConceptScore W2108673054C2779714933 @default.
• W2108673054 hasConceptScore W2108673054C38180746 @default.
• W2108673054 hasConceptScore W2108673054C509974204 @default.
• W2108673054 hasConceptScore W2108673054C71924100 @default.
• W2108673054 hasConceptScore W2108673054C86803240 @default.

• next